Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach

MBANYA J. C., AL-SIFRI S., ABDEL-RAHIM A., Satman I.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.109, sa.2, ss.226-232, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 109 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.diabres.2015.04.030
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.226-232
  • Anahtar Kelimeler: Ramadan, Diabetes, Gliclazide, GLUCOSE CONTROL, INSULIN SECRETAGOGUES, MUSLIM PATIENTS, DOUBLE-BLIND, SULFONYLUREA, VILDAGLIPTIN, SITAGLIPTIN, MANAGEMENT, MORTALITY, OUTCOMES
  • İstanbul Üniversitesi Adresli: Evet

Özet

Aim: Hypoglycemia can be a concern for patients with type 2 diabetes when fasting during Ramadan. In this analysis, we assessed the incidence of symptomatic hypoglycemic events in fasting patients treated with gliclazide or dipeptidyl peptidase-4 (DPP-4) inhibitors.